I recall the ASX putting special requirements on companies when reporting matters pertaining to covid 19 cures/trials/treatments. I'm unsure of the specifics but I'd suggest that management would rather play it conservatively than face the wrath of the regulator.
I recall the ASX putting special requirements on companies when...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.52M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4281 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 625000 | 2 |
View Market Depth
| Last trade - 07.00am 07/05/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable